CB Scientific (CB Scientific) Total Assets : $0.39 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CB Scientific Total Assets?

CB Scientific's Total Assets for the quarter that ended in Dec. 2023 was $0.39 Mil.

During the past 12 months, CB Scientific's average Total Assets Growth Rate was -4.90% per year.

Total Assets is connected with ROA %. CB Scientific's annualized ROA % for the quarter that ended in Dec. 2023 was -708.36%. Total Assets is also linked to Revenue through Asset Turnover. CB Scientific's Asset Turnover for the quarter that ended in Dec. 2023 was 0.10.

CB Scientific Total Assets Historical Data

The historical data trend for CB Scientific's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CB Scientific Total Assets Chart

CB Scientific Annual Data

Trend

Mar21

Mar22

Mar23

Total Assets

0.31

0.65

0.31

CB Scientific Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial							0.17	0.31	0.19	0.16	0.39

CB Scientific Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

CB Scientific's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	-0.377	+	0.682
	=	0.31

CB Scientific's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	-0.747	+	1.137
	=	0.39

CB Scientific (OTCPK:CBSC) Total Assets Explanation

Total Assets is connected with ROA %.

CB Scientific's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-1.948	/	( (0.16	+	0.39)	/ 2 )
	=	-1.948	/	0.275
	=	-708.36 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

CB Scientific's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.028	/	( (0.16	+	0.39)	/ 2 )
=	0.028	/	0.275
=	0.10

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

CB Scientific Total Assets Related Terms

Thank you for viewing the detailed overview of CB Scientific's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CB Scientific (CB Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CB Scientific Inc (OTCPK:CBSC) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135

Website

https://www.cbscientificinc.com

CB Scientific Inc through its U.S. and international subsidiaries provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.